|
⚲
|
| Keyboard |
| Marian Nakada | |
|---|---|
| Firm | |
| Address | 524 S Main St Suite 110 Ann Arbor, MI 48104 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| ONL Therapeutics Inc | 021-524116 | Director | 60.0 M of 65.0 M |
||
| Aliada Therapeutics Inc | 021-469243 | Director | 32.0 M of 32.0 M |
||
| Ribon Therapeutics Inc | 021-402745 | Director | 25.2 M of 60.2 M |
||
| Navitor Pharmaceuticals Inc | 021-366438 | Director | 20.2 M of 20.2 M |
||
| Artizan Biosciences Inc | 021-361935 | Director | 1.7 M of 2.0 M |
||
| Artizan Biosciences Inc | 021-334395 | Director | 5.0 M of 5.0 M |
||
| Ribon Therapeutics Inc | 021-329723 | Director | 25.4 M of 65.0 M |
||
| Redona Therapeutics Inc | 021-320722 | Director | 60.8 M of 76.9 M |
||
| Navitor Pharmaceuticals Inc | 021-253679 | Director | 12.0 M of 33.3 M |
||
| Navitor Pharmaceuticals Inc | 021-203891 | Director | 13.5 M of 23.5 M |
||
| Costim Pharmaceuticals Inc | 021-194766 | Director | 10.0 M of 22.3 M |
||